Effect of chronic treatment with the vasopeptidase inhibitor AVE 7688 and ramipril on endothelial function in atherogenic diet rabbits

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 4, Issue 3, 2003, Pages 191-196

  Weckler, Nadine ^a   Leitzbach, Daniela ^a   Kalinowski, Ludmila ^b   Malinski, Tadeusz ^b   Busch, Andreas E ^a   Linz, Wolfgang ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^b OHIO UNIVERSITY   (United States)

Author keywords

ACE NEP inhibition; Endothelial dysfunction; Hypercholesterolaemia; Rabbits

Indexed keywords

ANGIOTENSIN I; AVE 7688; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LIPID; NITRIC OXIDE; OXYGEN; RAMIPRIL; SUPEROXIDE; UNCLASSIFIED DRUG; VASOPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOAVAILABILITY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; ENDOTHELIUM LESION; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OBESITY; RABBIT; THORACIC AORTA; TREATMENT OUTCOME;

EID: 0242608644     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2003.031     Document Type: Article

References (25)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:488-500.
2. Schachinger V, Zeiher AM. Atherosclerosis-associated endothelial dysfunction. Z-Kardiol 2000,89(suppl 9IX):70-4.
3. Lüscher TF. Endothelial dysfunction in atherosclerosis. J Myocard Ischemia 1995;7(suppl 1): 15-20.
4. Levine GN, Keaney JF, Vita JA. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 1995;332:512-21.
5. Aikawa M, Rabkin E, Okada Y et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma. A potential mechanism of lesion stabilization. Circulation 1998;97:2433-44.
6. Becker RHA, Wiemer G, Linz W. Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharmacol 1991; 18(suppl 2):S110-S115.
7. Schuh JR, Blehm DJ, Frierdich GE, McMahon EG, Blaine EH. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest 1993;91: 1453-8.
8. Finta KM, Fischer MJ, Lee L, Gordan D, Pitt B, Webb RC. Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed with an atherogenic diet. Atherosclerosis 1993;100:149-56.
9. The Heart Outcome Prevention Evaluation Study Investigators. Effects of angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.
10. Kugiyama K, Sugiyama S, Matsumura T, Ohta Y, Doi H, Yasue H. Suppression of atherosclerotic changes in cholesterol-fed rabbits treated with an oral inhibitor of neutral endopeptidase. Arterioscler Thromb Vasc Biol 1996;16:1080-7.
11. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 1971;20:1637-48.
12. Malinski T, Taha Z. Nitric oxide release from a single cell measured in situ by it porphyrinic-based microsensor. Nature 1992;358:676-8.
13. Wiemer G, Linz W, Hatrik S, Schölkens BA, Malinski T. Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats. Hypertension 1997;30:1183-90.
14. Lvovich V, Scheeline A. Amperometric sensor for simultaneous superoxide and hydrogen peroxide detection. Anal Chem 1997;69:454-62.
15. Mesaros S, Vankova Z, Grunfeld S, Mesarosova A, Malinski T. Preparation and optimisation of superoxide microsensor. Anal Chem Acta 1998;358:27-31.
16. Nickenig G, Jung O, Strehlow K et al. Hypercholesterolaemia is associated with enhanced angiotensin AT1-receptor expression. Am J Physiol 1997;272:H2701-H2707.
17. Anderson MR, Stender S. Endothelial nitric oxide synthase activity in aorta of normocholesterolemic rabbits: regional variation and the effect of estrogen. Cardiovasc Res 2000;47:192-9.
18. Du ZY, Woodman OL. The effect of hypercholesterolemia and atherosclerosis on α-adrenoceptor-mediated vasoconstriction in conscious rabbits and rabbit aorta. Eur J Pharmacol 1991;11:149-56.
19. Fujiwara T, Chiba S. Alterations of vascular α1-adrenergic contractile responses in hypercholesterolemic rabbit common carotid arteries. J Cardiovasc Pharmacol 1993;22:58-64.
20. Hoshida S, Nishida M, Yamashita N et al. Amelioration of severity of myocardial injury by a nitric oxide donor in rabbits fed a cholesterol-rich diet. J Am Coll Cardiol 1996;27:902-09.
21. Woditsch I, Schrör K. Reduced endothelium-dependent relaxation and enhanced NO release in hearts of hypercholesterolaemic rabbits. Br J Pharmacol 1994;111:1035-40.
22. Pritchard KA Jr, Groszek L, Smalley DM et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 1995;77:510-18.
23. Quyyumil AA, Dakak N, Mulcahy D et al. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 1997;29:308-17.
24. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995;47:25-49.
25. Linz W, Wiemer G, Schölkens BA. Beneficial effects of bradykinin on myocardial energy metabolism and infarct size. Am J Cardiol 1997;80(3A):118A-123A.